Veropharm, one of Russia's largest drug makers, increased its IFRS net profit in the first nine months of 2010 by 14 percent year-on-year to 833.6 million rubles ($26.7 million), the company said on Friday.
Veropharm's sales in January-September 2010 grew by 22.4 percent to 3.934 billion rubles compared with the same period in 2009, the company said.
MOSCOW, November 26 (RIA Novosti)